Guardado en:
| Autores principales: | Andrea Gilmore‐Bykovskyi, Kayla Dillon, Beth Fields, Clark Benson, Dorothy Farrar Edwards |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.70052 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Using concept mapping to identify recruitment and engagement strategies for inclusion of LGBTQIA+ populations in Alzheimer's disease and related dementia research
por: Brittany Klenczar‐Castro, et al.
Publicado: (2024)
por: Brittany Klenczar‐Castro, et al.
Publicado: (2024)
Perspective: Minimal clinically important difference (MCID) and Alzheimer's disease clinical trials
por: Jeffrey Cummings
Publicado: (2025)
por: Jeffrey Cummings
Publicado: (2025)
Incorporating individually defined brain health priorities in clinical trial outcomes: the electronic Person‐Specific Outcome Measure approach in the United States
por: Stina Saunders, et al.
Publicado: (2025)
por: Stina Saunders, et al.
Publicado: (2025)
A psychometric study of the Flourishing Scale for people living with dementia
por: Chris Clarke, et al.
Publicado: (2025)
por: Chris Clarke, et al.
Publicado: (2025)
Two new positive psychosocial measures for persons living with dementia
por: Sheila L. Molony, et al.
Publicado: (2025)
por: Sheila L. Molony, et al.
Publicado: (2025)
Perspectives on meaningful dementia treatment and care from those with lived experience
por: Walter Moczygemba, et al.
Publicado: (2025)
por: Walter Moczygemba, et al.
Publicado: (2025)
Supporting dementia caregivers: The role of “lived experience” and public health collaboration
por: Chelsea Kline, et al.
Publicado: (2025)
por: Chelsea Kline, et al.
Publicado: (2025)
Care staff perspectives of clinically meaningful outcomes for dementia residents
por: Alaine E. Reschke‐Hernández, et al.
Publicado: (2025)
por: Alaine E. Reschke‐Hernández, et al.
Publicado: (2025)
Discrepancies between self‐ and proxy‐rated quality of life in people living with dementia
por: Maresa Buchholz, et al.
Publicado: (2024)
por: Maresa Buchholz, et al.
Publicado: (2024)
Meaningful benefit of disease‐modifying treatment: Evaluating changes in health‐related resource use
por: Carolyn W. Zhu, et al.
Publicado: (2024)
por: Carolyn W. Zhu, et al.
Publicado: (2024)
Electroencephalography‐based signatures of cognitive resilience in individuals with stable mild cognitive impairment despite carrying a high‐risk for progression to dementia
por: Chiara Pappalettera, et al.
Publicado: (2025)
por: Chiara Pappalettera, et al.
Publicado: (2025)
A service‐oriented approach to clinical trial recruitment for dementia and brain health: Methods and case examples of MyAlliance for Brain Health
por: Eric D. Vidoni, et al.
Publicado: (2024)
por: Eric D. Vidoni, et al.
Publicado: (2024)
Sick sinus syndrome and high‐degree atrioventricular block in dementia with Lewy bodies and other dementia subtypes: A study of ≈ 73,000 patients with dementia
por: Isak Heyman, et al.
Publicado: (2025)
por: Isak Heyman, et al.
Publicado: (2025)
The momentum for dementia research in Brazil
por: Mychael V. Lourenco
Publicado: (2026)
por: Mychael V. Lourenco
Publicado: (2026)
Systematic review and meta‐analysis of antipsychotic discontinuation in dementia
por: Sophie Roche, et al.
Publicado: (2025)
por: Sophie Roche, et al.
Publicado: (2025)
Awareness and cognitive rehabilitation in Alzheimer's disease and frontotemporal dementia
por: Eric Salmon, et al.
Publicado: (2024)
por: Eric Salmon, et al.
Publicado: (2024)
Anti‐epileptic drug use and subsequent degenerative dementia occurrence
por: Naoki Ikegaya, et al.
Publicado: (2024)
por: Naoki Ikegaya, et al.
Publicado: (2024)
Vascular cognitive impairment and dementia drug‐development pipeline 2025
por: Ying Xu, et al.
Publicado: (2026)
por: Ying Xu, et al.
Publicado: (2026)
Patterns and predictors of cholinesterase inhibitor use in dementia with Lewy bodies
por: Rachel J. Heo, et al.
Publicado: (2025)
por: Rachel J. Heo, et al.
Publicado: (2025)
Profiling the needs of dementia caregivers in a Brazilian cross‐sectional study
por: Alan Cronemberger Andrade, et al.
Publicado: (2025)
por: Alan Cronemberger Andrade, et al.
Publicado: (2025)
Locus coeruleus alterations in dementia with Lewy bodies: A systematic review
por: Anaëlle Bain, et al.
Publicado: (2026)
por: Anaëlle Bain, et al.
Publicado: (2026)
The association of dementia risk symptoms and functional activity in adults with Down syndrome
por: Selena E. Washington, et al.
Publicado: (2024)
por: Selena E. Washington, et al.
Publicado: (2024)
Resources for estimating dementia prevalence at the state and local levels in the United States
por: Erin E. Bennett, et al.
Publicado: (2026)
por: Erin E. Bennett, et al.
Publicado: (2026)
Clinically meaningful outcomes in Alzheimer's disease and Alzheimer's disease related dementias trials
por: Luke E. Stoeckel, et al.
Publicado: (2025)
por: Luke E. Stoeckel, et al.
Publicado: (2025)
Statin use and dementia risk: A systematic review and updated meta‐analysis
por: Fernando Luiz Westphal Filho, et al.
Publicado: (2025)
por: Fernando Luiz Westphal Filho, et al.
Publicado: (2025)
A common outcome set for trials in dementia with Lewy bodies (DLB COS)
por: Joseph P. M. Kane, et al.
Publicado: (2025)
por: Joseph P. M. Kane, et al.
Publicado: (2025)
Rural–urban disparities of Alzheimer's disease and related dementias: A scoping review
por: Mackenzie Kramer, et al.
Publicado: (2025)
por: Mackenzie Kramer, et al.
Publicado: (2025)
Immediate reactions to amyloid PET disclosure in Japanese older adults without dementia
por: Kenichiro Sato, et al.
Publicado: (2025)
por: Kenichiro Sato, et al.
Publicado: (2025)
Unforgettable: The power of community in the pursuit of health equity for Alzheimer's disease and other dementia
por: Beverly M. Berry, et al.
Publicado: (2025)
por: Beverly M. Berry, et al.
Publicado: (2025)
The utility of a composite endpoint for tracking disease progression in Lewy body dementia
por: Elie Matar, et al.
Publicado: (2026)
por: Elie Matar, et al.
Publicado: (2026)
Assessing clinical meaningfulness in clinical trials for Alzheimer's disease: A U.S. regulatory perspective
por: Teresa Buracchio, et al.
Publicado: (2025)
por: Teresa Buracchio, et al.
Publicado: (2025)
AI approaches for phenotyping Alzheimer's disease and related dementias using electronic health records
por: Sara Knox, et al.
Publicado: (2025)
por: Sara Knox, et al.
Publicado: (2025)
Person‐centered care at population scale: The Swedish registry for behavioral and psychological symptoms of dementia
por: Linus Jönsson, et al.
Publicado: (2025)
por: Linus Jönsson, et al.
Publicado: (2025)
An environmental scan of equity‐related measures for the certified nursing assistant dementia care workforce
por: Jasmine L. Travers, et al.
Publicado: (2024)
por: Jasmine L. Travers, et al.
Publicado: (2024)
Anticholinergic drugs and dementia risk: Using stem cell–based studies to complement pharmacoepidemiology
por: Tiara A. Schwarze‐Taufiq, et al.
Publicado: (2025)
por: Tiara A. Schwarze‐Taufiq, et al.
Publicado: (2025)
Data‐driven discovery of associations between prescribed drugs and dementia risk: A systematic review
por: Benjamin R. Underwood, et al.
Publicado: (2025)
por: Benjamin R. Underwood, et al.
Publicado: (2025)
Association of allostatic load with all‐cause and cause‐specific dementia: A prospective cohort study
por: Yifan Gou, et al.
Publicado: (2025)
por: Yifan Gou, et al.
Publicado: (2025)
From companionship to science: the importance of dogs in advancing translational research on Alzheimer's disease – a scoping review
por: Heloísa Máximo Ribeiro, et al.
Publicado: (2026)
por: Heloísa Máximo Ribeiro, et al.
Publicado: (2026)
Potential of low‐field MRI for increasing participation of Filipino Americans and underrepresented populations in Alzheimer's and dementia research
por: Mikkael Lamoca, et al.
Publicado: (2025)
por: Mikkael Lamoca, et al.
Publicado: (2025)
Constructive engagement in cognitive stimulation therapy groups among people with dementia: A mixed‐methods study
por: Anna Yan Zhang, et al.
Publicado: (2025)
por: Anna Yan Zhang, et al.
Publicado: (2025)
Ejemplares similares
-
Using concept mapping to identify recruitment and engagement strategies for inclusion of LGBTQIA+ populations in Alzheimer's disease and related dementia research
por: Brittany Klenczar‐Castro, et al.
Publicado: (2024) -
Perspective: Minimal clinically important difference (MCID) and Alzheimer's disease clinical trials
por: Jeffrey Cummings
Publicado: (2025) -
Incorporating individually defined brain health priorities in clinical trial outcomes: the electronic Person‐Specific Outcome Measure approach in the United States
por: Stina Saunders, et al.
Publicado: (2025) -
A psychometric study of the Flourishing Scale for people living with dementia
por: Chris Clarke, et al.
Publicado: (2025) -
Two new positive psychosocial measures for persons living with dementia
por: Sheila L. Molony, et al.
Publicado: (2025)